Establishment Labs Holdings (ESTA) Amortization of Deferred Charges (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Amortization of Deferred Charges came in at $214000.0 in Q1 2026, down 7.36% year-on-year from $231000.0 in Q1 2025, and down 92.41% quarter-over-quarter from $2.8 million in Q4 2025.
Establishment Labs Holdings (ESTA) Amortization of Deferred Charges (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Amortization of Deferred Charges history runs 10 years deep, the most recent figure standing at $214000.0 for Q1 2026.
- On a quarterly basis, Amortization of Deferred Charges fell 7.36% year-over-year to $214000.0 in Q1 2026; TTM through Mar 2026 was $3.4 million, a 238.62% increase from a year earlier, with the FY2025 full-year figure at $3.4 million, up 363.66% from the prior year.
- Amortization of Deferred Charges fell to $214000.0 in Q1 2026 per ESTA's latest filing, from $2.8 million in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $6.3 million in Q2 2023 and bottomed at -$6.0 million in Q3 2023.
- The 5-year median for Amortization of Deferred Charges is $177000.0 (2023), against an average of $328705.9.
- Across the five-year window, Amortization of Deferred Charges sank 4912.1% in 2023 and jumped 1847.46% in 2024, its largest moves.
- Year by year, Amortization of Deferred Charges stood at $158000.0 in 2022, then advanced by 10.76% to $175000.0 in 2023, then plunged by 2888.0% to -$4.9 million in 2024, then soared by 157.78% to $2.8 million in 2025, then tumbled by 92.41% to $214000.0 in 2026.
- Per Business Quant, the three latest ESTA Amortization of Deferred Charges figures stand at $214000.0 (Q1 2026), $2.8 million (Q4 2025), and $154000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn |
| 10 | Establishment Labs Holdings | 2.75 Bn | 2.69 Bn | 42.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 214,000.00 |
| Mar 31, 2026 | 214,000.00 |
| Dec 31, 2025 | 2.82 Mn |
| Dec 31, 2025 | 2.82 Mn |
| Sep 30, 2025 | 154,000.00 |
| Sep 30, 2025 | 154,000.00 |
| Jun 30, 2025 | 241,000.00 |
| Jun 30, 2025 | 241,000.00 |
| Mar 31, 2025 | 231,000.00 |
| Mar 31, 2025 | 231,000.00 |
| Dec 31, 2024 | -4.88 Mn |
| Dec 31, 2024 | -4.88 Mn |
| Sep 30, 2024 | 5.32 Mn |
| Sep 30, 2024 | 5.32 Mn |
| Jun 30, 2024 | -3.14 Mn |
| Jun 30, 2024 | -3.14 Mn |
| Mar 31, 2024 | 3.45 Mn |
| Mar 31, 2024 | 3.45 Mn |
| Dec 31, 2023 | 175,000.00 |
| Dec 31, 2023 | 175,000.00 |